SYSTEM PROBLEMS:
We are currently experiencing technical problems with content and functionality requiring a login.
We apologize for the inconvience.
Showing session: reset
CLINICAL PHARMACOLOGY OF HIV-TB COINFECTION
- Sort by:
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
6 of
6
|
DRUG-DRUG INTERACTIONS IN HIV-ASSOCIATED TB: BALANCING EVIDENCE, RISK, AND PRAGMATISM (ABSTRACT
1159)
Gary Maartens
University of Cape Town, Cape Town , South Africa
EFAVIRENZ PHARMACOKINETICS IN HIV/TB COINFECTED PERSONS RECEIVING RIFAPENTINE (ABSTRACT
455)
Anthony Podany
University of Nebraska, Omaha, NE, USA
EFAVIRENZ PHARMACOKINETICS WITH RIFAMPIN DOUBLE DOSE IN TB-HIV INFECTED PATIENTS (ABSTRACT
456)
Daniel Warren Atwine
MSF-Epicentre, Mbarara, Uganda
PHARMACOKINETICS OF EFAVIRENZ 400MG WITH ISONIAZID/RIFAMPICIN IN PEOPLE WITH HIV (ABSTRACT
457)
Maddalena Cerrone
St Stephen's Clinical Research, Chelsea and Westminster Hospital, London, UK, LONDON, United Kingdom
IN SILICO DRUG INTERACTION OF LONG-ACTING RILPIVIRINE AND CABOTEGRAVIR WITH RIFAMPIN (ABSTRACT
458)
Rajith Kumar Reddy Rajoli
University of Liverpool, Liverpool, Merseyside, United Kingdom
|
<< first | < prev
page:
of 1
|
records per page:
next > | last >>
|
| pages: 1
|
presentations:
1 to
6 of
6
|
